Literature DB >> 7758481

Diversity of nosocomial Xanthomonas maltophilia (Stenotrophomonas maltophilia) as determined by ribotyping.

P Gerner-Smidt1, B Bruun, M Arpi, J Schmidt.   

Abstract

Seventy-seven clinical isolates of Xanthomonas maltophilia (Stenotrophomonas maltophilia) were consecutively collected from the Rigshospitalet, Copenhagen, ribotyped and compared with the ribotypes of 25 other clinical and reference strains of Xanthomonas maltophilia. Using restriction enzyme EcoRI, 20 different ribotypes were observed, with 78 isolates displaying the five most common types. Using another enzyme, BamHI, these 78 isolates were further subdivided into 16 different ribotypes. Three patients harboured two strains with different ribotypes. No type was found related to only one department and no single-strain outbreak was detected. The origin of this wealth of different strains in hospital patients needs to be established.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7758481     DOI: 10.1007/BF02111874

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  15 in total

1.  Predisposing factors and antibiotic use in nosocomial infections caused by Xanthomonas maltophilia.

Authors:  D T Hulisz; T M File
Journal:  Infect Control Hosp Epidemiol       Date:  1992-08       Impact factor: 3.254

2.  Nosocomial infections due to Xanthomonas maltophilia (Pseudomonas maltophilia) in patients with cancer.

Authors:  N Khardori; L Elting; E Wong; B Schable; G P Bodey
Journal:  Rev Infect Dis       Date:  1990 Nov-Dec

3.  Nosocomial infection caused by Xanthomonas maltophilia: a case-control study of predisposing factors.

Authors:  L S Elting; N Khardori; G P Bodey; V Fainstein
Journal:  Infect Control Hosp Epidemiol       Date:  1990-03       Impact factor: 3.254

4.  Epidemiological studies of Pseudomonas species in patients with leukemia.

Authors:  G P Bodey
Journal:  Am J Med Sci       Date:  1970-08       Impact factor: 2.378

5.  Septicemia due to Xanthomonas species and non-aeruginosa Pseudomonas species: increasing incidence of catheter-related infections.

Authors:  L S Elting; G P Bodey
Journal:  Medicine (Baltimore)       Date:  1990-09       Impact factor: 1.889

6.  Rapid inter-strain comparison by pyrolysis mass spectrometry in nosocomial infection with Xanthomonas maltophilia.

Authors:  K Orr; F K Gould; P R Sisson; N F Lightfoot; R Freeman; D Burdess
Journal:  J Hosp Infect       Date:  1991-03       Impact factor: 3.926

7.  DNA restriction fragment length polymorphism differentiates crossed from independent infections in nosocomial Xanthomonas maltophilia bacteremia.

Authors:  E H Bingen; E Denamur; N Y Lambert-Zechovsky; A Bourdois; P Mariani-Kurkdjian; J P Cezard; J Navarro; J Elion
Journal:  J Clin Microbiol       Date:  1991-07       Impact factor: 5.948

8.  Typing of hospital strains of Xanthomonas maltophilia by pulsed-field gel electrophoresis.

Authors:  D Talon; P Bailly; R Leprat; C Godard; E Deconnink; J Y Cahn; Y Michel-Briand
Journal:  J Hosp Infect       Date:  1994-07       Impact factor: 3.926

9.  Associated mortality and clinical characteristics of nosocomial Pseudomonas maltophilia in a university hospital.

Authors:  A J Morrison; K K Hoffmann; R P Wenzel
Journal:  J Clin Microbiol       Date:  1986-07       Impact factor: 5.948

Review 10.  beta-Lactam resistance in gram-negative bacteria: global trends and clinical impact.

Authors:  C C Sanders; W E Sanders
Journal:  Clin Infect Dis       Date:  1992-11       Impact factor: 9.079

View more
  7 in total

1.  Comparison of antifungal activities and 16S ribosomal DNA sequences of clinical and environmental isolates of Stenotrophomonas maltophilia.

Authors:  A Minkwitz; G Berg
Journal:  J Clin Microbiol       Date:  2001-01       Impact factor: 5.948

2.  Use of random amplified polymorphic DNA PCR to examine epidemiology of Stenotrophomonas maltophilia and Achromobacter (Alcaligenes) xylosoxidans from patients with cystic fibrosis.

Authors:  J W Krzewinski; C D Nguyen; J M Foster; J L Burns
Journal:  J Clin Microbiol       Date:  2001-10       Impact factor: 5.948

Review 3.  Microbiological and clinical aspects of infection associated with Stenotrophomonas maltophilia.

Authors:  M Denton; K G Kerr
Journal:  Clin Microbiol Rev       Date:  1998-01       Impact factor: 26.132

Review 4.  Stenotrophomonas maltophilia: an emerging global opportunistic pathogen.

Authors:  Joanna S Brooke
Journal:  Clin Microbiol Rev       Date:  2012-01       Impact factor: 26.132

5.  Genotypic and phenotypic relationships between clinical and environmental isolates of Stenotrophomonas maltophilia.

Authors:  G Berg; N Roskot; K Smalla
Journal:  J Clin Microbiol       Date:  1999-11       Impact factor: 5.948

6.  Molecular epidemiology of Stenotrophomonas maltophilia isolated from clinical specimens from patients with cystic fibrosis and associated environmental samples.

Authors:  M Denton; N J Todd; K G Kerr; P M Hawkey; J M Littlewood
Journal:  J Clin Microbiol       Date:  1998-07       Impact factor: 5.948

7.  Friends or foes: can we make a distinction between beneficial and harmful strains of the Stenotrophomonas maltophilia complex?

Authors:  Gabriele Berg; Jose L Martinez
Journal:  Front Microbiol       Date:  2015-03-31       Impact factor: 5.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.